Analystreport

PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.

PhaseBio Pharmaceuticals, Inc.  (PHAS) 
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am Check Earnings Report